PDT:
Pacific Daylight Time
PDT:
Pacific Daylight Time
Symposium Sessions
Live Now:
MAR10
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Deciphering the Mystery of Viral Rebound
4:00 PM4:00 PM
18 - Utilizing a Barcoded Virus Model to Identify the Source of Viral Rebound
Brandon Keele
Frederick National Laboratory for Cancer Research, Frederick, MD, USA
4:20 PM4:20 PM
19 - Cellular and Tissue Sources of Viral Persistence and Rebound
Linos Vandekerckhove
HIV Cure Research Center, Ghent University, Ghent, Belgium
4:40 PM4:40 PM
20 - Immune Responses During Viral Rebound
Rachel Rutishauser
University of California San Francisco, San Francisco, CA, USA
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR10
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Filling the Gaps: Challenges and Opportunities in the Care of Children and Youth With Perinatal HIV
4:00 PM4:00 PM
21 - Advanced HIV Disease in Children
Pablo Rojo
Hospital Universitario 12 de Octubre, Madrid, Spain
4:20 PM4:20 PM
22 - HIV Care Continuum in Children
Irene Njuguna
University of Washington, Seattle, WA, USA
4:40 PM4:40 PM
23 - Sexual, Reproductive, and Pregnancy Health Among People With Perinatal HIV
Caroline Foster
Imperial College Healthcare NHS Trust, London, UK
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR10
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Closing the Gaps in the HIV Response
4:00 PM4:00 PM
24 - Immediate Challenges and Long-Term Goals of the HIV Response
Jeffrey Imai-Eaton
Harvard TH Chan School of Public Health
4:20 PM4:20 PM
25 - Integration and Sustainability of the Global HIV Response
Tsitsi Apollo
Zimbabwe Ministry of Health and Child Care, Harare, Zimbabwe
4:40 PM4:40 PM
26 - Innovations in HIV Service Delivery: Building a Path Forward with Those Left Behind
Izukanji Sikazwe
Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR11
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Breaking In and Setting Up Home: From HIV Nuclear Entry and Integration to Viral Gene Expression and Establishing the Reservoir
4:00 PM4:00 PM
29 - How HIV Capsid Breaches the Nuclear Envelope Through Karyopherin Mimicry
David Jacques
University of New South Wales, Sydney, Australia
4:18 PM4:18 PM
30 - How HIV Integrates Into the Genome
Alan N Engelman
Dana–Farber Cancer Institute, Boston, MA, USA
4:36 PM4:36 PM
31 - Transcriptional and Epigenetic Regulation of HIV-1 Gene Expression
Melanie Ott
Gladstone Institutes, San Francisco, CA, USA
4:54 PM4:54 PM
32 - The Landscape of Proviral Integration in the HIV-1 Reservoir and Its Relationship to Latency and Reactivation
Mary Kearney
National Cancer Institute at Frederick, Frederick, MD, USA
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
4:00 PM4:00 PM
33 - Beyond Hot Flashes: Women's Lived Experience of Menopause
Bridgette Picou
The Well Project: Women's Research Initiative on HIV/AIDS, Brooklyn, NY, USA
4:10 PM4:10 PM
34 - Clinical Management of Women With HIV in Menopause
Sara Looby
Massachusetts General Hospital, Boston, MA, USA
4:25 PM4:25 PM
35 - Influence of Hormone Changes on Physiology, Virology, and Immunology
Eileen Scully
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
5:00 PM5:00 PM
Discussion with Audience Questions and Answers
MAR11
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Long-Acting Preexposure Prophylaxis for HIV Prevention
4:00 PM4:00 PM
38 - Game Changed: Navigating the Era of Long-Acting Therapies for HIV Prevention
Jonathan Li
Brigham and Women's Hospital, Boston, MA, USA
4:20 PM4:20 PM
39 - Complexities of HIV Diagnosis: What Lies Beneath
Cheryl C. Johnson
World Health Organization, Geneva, Switzerland
4:40 PM4:40 PM
40 - Long-Acting Preexposure Prophylaxis: Why Can’t We Get to Scale?
Cissy Kityo
Joint Clinical Research Centre, Kampala, Uganda
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
5:00 PM5:00 PM
36 - Long-Acting Treatments for Tuberculosis
Eric Nuermberger
The Johns Hopkins University, Baltimore, MD, USA
5:20 PM5:20 PM
37 - Post-Tuberculosis Disease: Opening Pandora's Box
Brian Allwood
Stellenbosch University, Cape Town, South Africa
6:00 PM6:00 PM
Discussion with Audience Questions and Answers
MAR12
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Pathogenesis of HIV in the Brain: The Final Frontier
4:00 PM4:00 PM
43 - Multiomics in the Brain
Howard Fox
University of Nebraska, Omaha, NE, USA
4:20 PM4:20 PM
44 - The Central Nervous System Reservoir: Impact for Cure and Ongoing Neuropathology
Melissa Churchill
Royal Melbourne Institute of Technology, Melbourne, Australia
4:40 PM4:40 PM
45 - Emerging Role of T Cells in the Central Nervous System
Lydie Trautmann
Henry M Jackson Foundation, Bethesda, MD, USA
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR12
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Making Sense of Integrase Strand Transfer Inhibitor Failure and Resistance
4:00 PM4:00 PM
46 - Dolutegravir Resistance: How Frequent Is It and How Will It Evolve?
Nicaise Ndembi
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia
4:20 PM4:20 PM
47 - Dolutegravir Resistance: What Are the Implications for Antiretroviral Therapy Programs?
Jeremy Nel
University of Witwatersrand, Johannesburg, South Africa
4:40 PM4:40 PM
48 - Long-Acting InSTI Strategies: Understanding the Risks for Failure and Resistance
Saye Khoo
University of Liverpool, Liverpool, UK
5:00 PM5:00 PM
Panel Discussion
Brenda E. Crabtree Ramírez
National Institute of Medical Science and Nutrition Salvador Zubiran, Mexico City, Mexico
5:00 PM5:00 PM
Panel Discussion
Suzanne McCluskey
Massachusetts General Hospital, Boston, MA, USA
5:00 PM5:00 PM
Panel Discussion
Anna Turkova
MRC Clinical Trials Unit at UCL, London, UK
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR12
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Putting People at the Center of Prevention: New Models of Delivery
4:00 PM4:00 PM
49 - Leveraging Private-Sector Pharmacies to Expand Reach of Biomedical HIV Prevention Interventions
Katrina Ortblad
Fred Hutchinson Cancer Center, Seattle, WA, USA
4:20 PM4:20 PM
50 - Empowering Communities: A Peer-Based Model for Expanding Equitable Access to PrEP and PEP in Mexico
Alaín Pinzón
Vihve Libre, Mexico City, Mexico
4:40 PM4:40 PM
51 - We’ll Come to You: A Mobile Clinic Preexposure Prophylaxis Delivery Model
Elzette Rousseau
Desmond Tutu HIV Foundation, Cape Town, South Africa
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
Upcoming:
MAR10
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Deciphering the Mystery of Viral Rebound
4:00 PM4:00 PM
18 - Utilizing a Barcoded Virus Model to Identify the Source of Viral Rebound
Brandon Keele
Frederick National Laboratory for Cancer Research, Frederick, MD, USA
4:20 PM4:20 PM
19 - Cellular and Tissue Sources of Viral Persistence and Rebound
Linos Vandekerckhove
HIV Cure Research Center, Ghent University, Ghent, Belgium
4:40 PM4:40 PM
20 - Immune Responses During Viral Rebound
Rachel Rutishauser
University of California San Francisco, San Francisco, CA, USA
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR10
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Filling the Gaps: Challenges and Opportunities in the Care of Children and Youth With Perinatal HIV
4:00 PM4:00 PM
21 - Advanced HIV Disease in Children
Pablo Rojo
Hospital Universitario 12 de Octubre, Madrid, Spain
4:20 PM4:20 PM
22 - HIV Care Continuum in Children
Irene Njuguna
University of Washington, Seattle, WA, USA
4:40 PM4:40 PM
23 - Sexual, Reproductive, and Pregnancy Health Among People With Perinatal HIV
Caroline Foster
Imperial College Healthcare NHS Trust, London, UK
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR10
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Closing the Gaps in the HIV Response
4:00 PM4:00 PM
24 - Immediate Challenges and Long-Term Goals of the HIV Response
Jeffrey Imai-Eaton
Harvard TH Chan School of Public Health
4:20 PM4:20 PM
25 - Integration and Sustainability of the Global HIV Response
Tsitsi Apollo
Zimbabwe Ministry of Health and Child Care, Harare, Zimbabwe
4:40 PM4:40 PM
26 - Innovations in HIV Service Delivery: Building a Path Forward with Those Left Behind
Izukanji Sikazwe
Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR11
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Breaking In and Setting Up Home: From HIV Nuclear Entry and Integration to Viral Gene Expression and Establishing the Reservoir
4:00 PM4:00 PM
29 - How HIV Capsid Breaches the Nuclear Envelope Through Karyopherin Mimicry
David Jacques
University of New South Wales, Sydney, Australia
4:18 PM4:18 PM
30 - How HIV Integrates Into the Genome
Alan N Engelman
Dana–Farber Cancer Institute, Boston, MA, USA
4:36 PM4:36 PM
31 - Transcriptional and Epigenetic Regulation of HIV-1 Gene Expression
Melanie Ott
Gladstone Institutes, San Francisco, CA, USA
4:54 PM4:54 PM
32 - The Landscape of Proviral Integration in the HIV-1 Reservoir and Its Relationship to Latency and Reactivation
Mary Kearney
National Cancer Institute at Frederick, Frederick, MD, USA
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR11
4:00 PMto5:00 PMPDT
12:00 PMto5:00 PMPDT
Hot Topic: Menopause and HIV
4:00 PM4:00 PM
33 - Beyond Hot Flashes: Women's Lived Experience of Menopause
Bridgette Picou
The Well Project: Women's Research Initiative on HIV/AIDS, Brooklyn, NY, USA
4:10 PM4:10 PM
34 - Clinical Management of Women With HIV in Menopause
Sara Looby
Massachusetts General Hospital, Boston, MA, USA
4:25 PM4:25 PM
35 - Influence of Hormone Changes on Physiology, Virology, and Immunology
Eileen Scully
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
5:00 PM5:00 PM
Discussion with Audience Questions and Answers
MAR11
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Long-Acting Preexposure Prophylaxis for HIV Prevention
4:00 PM4:00 PM
38 - Game Changed: Navigating the Era of Long-Acting Therapies for HIV Prevention
Jonathan Li
Brigham and Women's Hospital, Boston, MA, USA
4:20 PM4:20 PM
39 - Complexities of HIV Diagnosis: What Lies Beneath
Cheryl C. Johnson
World Health Organization, Geneva, Switzerland
4:40 PM4:40 PM
40 - Long-Acting Preexposure Prophylaxis: Why Can’t We Get to Scale?
Cissy Kityo
Joint Clinical Research Centre, Kampala, Uganda
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR11
5:00 PMto6:00 PMPDT
12:00 PMto5:00 PMPDT
Tuberculosis: The Long Game
5:00 PM5:00 PM
36 - Long-Acting Treatments for Tuberculosis
Eric Nuermberger
The Johns Hopkins University, Baltimore, MD, USA
5:20 PM5:20 PM
37 - Post-Tuberculosis Disease: Opening Pandora's Box
Brian Allwood
Stellenbosch University, Cape Town, South Africa
6:00 PM6:00 PM
Discussion with Audience Questions and Answers
MAR12
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Pathogenesis of HIV in the Brain: The Final Frontier
4:00 PM4:00 PM
43 - Multiomics in the Brain
Howard Fox
University of Nebraska, Omaha, NE, USA
4:20 PM4:20 PM
44 - The Central Nervous System Reservoir: Impact for Cure and Ongoing Neuropathology
Melissa Churchill
Royal Melbourne Institute of Technology, Melbourne, Australia
4:40 PM4:40 PM
45 - Emerging Role of T Cells in the Central Nervous System
Lydie Trautmann
Henry M Jackson Foundation, Bethesda, MD, USA
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR12
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Making Sense of Integrase Strand Transfer Inhibitor Failure and Resistance
4:00 PM4:00 PM
46 - Dolutegravir Resistance: How Frequent Is It and How Will It Evolve?
Nicaise Ndembi
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia
4:20 PM4:20 PM
47 - Dolutegravir Resistance: What Are the Implications for Antiretroviral Therapy Programs?
Jeremy Nel
University of Witwatersrand, Johannesburg, South Africa
4:40 PM4:40 PM
48 - Long-Acting InSTI Strategies: Understanding the Risks for Failure and Resistance
Saye Khoo
University of Liverpool, Liverpool, UK
5:00 PM5:00 PM
Panel Discussion
Brenda E. Crabtree Ramírez
National Institute of Medical Science and Nutrition Salvador Zubiran, Mexico City, Mexico
5:00 PM5:00 PM
Panel Discussion
Suzanne McCluskey
Massachusetts General Hospital, Boston, MA, USA
5:00 PM5:00 PM
Panel Discussion
Anna Turkova
MRC Clinical Trials Unit at UCL, London, UK
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR12
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Putting People at the Center of Prevention: New Models of Delivery
4:00 PM4:00 PM
49 - Leveraging Private-Sector Pharmacies to Expand Reach of Biomedical HIV Prevention Interventions
Katrina Ortblad
Fred Hutchinson Cancer Center, Seattle, WA, USA
4:20 PM4:20 PM
50 - Empowering Communities: A Peer-Based Model for Expanding Equitable Access to PrEP and PEP in Mexico
Alaín Pinzón
Vihve Libre, Mexico City, Mexico
4:40 PM4:40 PM
51 - We’ll Come to You: A Mobile Clinic Preexposure Prophylaxis Delivery Model
Elzette Rousseau
Desmond Tutu HIV Foundation, Cape Town, South Africa
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
Previous:
MAR10
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Deciphering the Mystery of Viral Rebound
4:00 PM4:00 PM
18 - Utilizing a Barcoded Virus Model to Identify the Source of Viral Rebound
Brandon Keele
Frederick National Laboratory for Cancer Research, Frederick, MD, USA
4:20 PM4:20 PM
19 - Cellular and Tissue Sources of Viral Persistence and Rebound
Linos Vandekerckhove
HIV Cure Research Center, Ghent University, Ghent, Belgium
4:40 PM4:40 PM
20 - Immune Responses During Viral Rebound
Rachel Rutishauser
University of California San Francisco, San Francisco, CA, USA
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR10
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Filling the Gaps: Challenges and Opportunities in the Care of Children and Youth With Perinatal HIV
4:00 PM4:00 PM
21 - Advanced HIV Disease in Children
Pablo Rojo
Hospital Universitario 12 de Octubre, Madrid, Spain
4:20 PM4:20 PM
22 - HIV Care Continuum in Children
Irene Njuguna
University of Washington, Seattle, WA, USA
4:40 PM4:40 PM
23 - Sexual, Reproductive, and Pregnancy Health Among People With Perinatal HIV
Caroline Foster
Imperial College Healthcare NHS Trust, London, UK
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR10
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Closing the Gaps in the HIV Response
4:00 PM4:00 PM
24 - Immediate Challenges and Long-Term Goals of the HIV Response
Jeffrey Imai-Eaton
Harvard TH Chan School of Public Health
4:20 PM4:20 PM
25 - Integration and Sustainability of the Global HIV Response
Tsitsi Apollo
Zimbabwe Ministry of Health and Child Care, Harare, Zimbabwe
4:40 PM4:40 PM
26 - Innovations in HIV Service Delivery: Building a Path Forward with Those Left Behind
Izukanji Sikazwe
Centre for Infectious Disease Research in Zambia, Lusaka, Zambia
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR11
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Breaking In and Setting Up Home: From HIV Nuclear Entry and Integration to Viral Gene Expression and Establishing the Reservoir
4:00 PM4:00 PM
29 - How HIV Capsid Breaches the Nuclear Envelope Through Karyopherin Mimicry
David Jacques
University of New South Wales, Sydney, Australia
4:18 PM4:18 PM
30 - How HIV Integrates Into the Genome
Alan N Engelman
Dana–Farber Cancer Institute, Boston, MA, USA
4:36 PM4:36 PM
31 - Transcriptional and Epigenetic Regulation of HIV-1 Gene Expression
Melanie Ott
Gladstone Institutes, San Francisco, CA, USA
4:54 PM4:54 PM
32 - The Landscape of Proviral Integration in the HIV-1 Reservoir and Its Relationship to Latency and Reactivation
Mary Kearney
National Cancer Institute at Frederick, Frederick, MD, USA
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR11
4:00 PMto5:00 PMPDT
12:00 PMto5:00 PMPDT
Hot Topic: Menopause and HIV
4:00 PM4:00 PM
33 - Beyond Hot Flashes: Women's Lived Experience of Menopause
Bridgette Picou
The Well Project: Women's Research Initiative on HIV/AIDS, Brooklyn, NY, USA
4:10 PM4:10 PM
34 - Clinical Management of Women With HIV in Menopause
Sara Looby
Massachusetts General Hospital, Boston, MA, USA
4:25 PM4:25 PM
35 - Influence of Hormone Changes on Physiology, Virology, and Immunology
Eileen Scully
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
5:00 PM5:00 PM
Discussion with Audience Questions and Answers
MAR11
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Long-Acting Preexposure Prophylaxis for HIV Prevention
4:00 PM4:00 PM
38 - Game Changed: Navigating the Era of Long-Acting Therapies for HIV Prevention
Jonathan Li
Brigham and Women's Hospital, Boston, MA, USA
4:20 PM4:20 PM
39 - Complexities of HIV Diagnosis: What Lies Beneath
Cheryl C. Johnson
World Health Organization, Geneva, Switzerland
4:40 PM4:40 PM
40 - Long-Acting Preexposure Prophylaxis: Why Can’t We Get to Scale?
Cissy Kityo
Joint Clinical Research Centre, Kampala, Uganda
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR11
5:00 PMto6:00 PMPDT
12:00 PMto5:00 PMPDT
Tuberculosis: The Long Game
5:00 PM5:00 PM
36 - Long-Acting Treatments for Tuberculosis
Eric Nuermberger
The Johns Hopkins University, Baltimore, MD, USA
5:20 PM5:20 PM
37 - Post-Tuberculosis Disease: Opening Pandora's Box
Brian Allwood
Stellenbosch University, Cape Town, South Africa
6:00 PM6:00 PM
Discussion with Audience Questions and Answers
MAR12
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Pathogenesis of HIV in the Brain: The Final Frontier
4:00 PM4:00 PM
43 - Multiomics in the Brain
Howard Fox
University of Nebraska, Omaha, NE, USA
4:20 PM4:20 PM
44 - The Central Nervous System Reservoir: Impact for Cure and Ongoing Neuropathology
Melissa Churchill
Royal Melbourne Institute of Technology, Melbourne, Australia
4:40 PM4:40 PM
45 - Emerging Role of T Cells in the Central Nervous System
Lydie Trautmann
Henry M Jackson Foundation, Bethesda, MD, USA
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR12
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Making Sense of Integrase Strand Transfer Inhibitor Failure and Resistance
4:00 PM4:00 PM
46 - Dolutegravir Resistance: How Frequent Is It and How Will It Evolve?
Nicaise Ndembi
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia
4:20 PM4:20 PM
47 - Dolutegravir Resistance: What Are the Implications for Antiretroviral Therapy Programs?
Jeremy Nel
University of Witwatersrand, Johannesburg, South Africa
4:40 PM4:40 PM
48 - Long-Acting InSTI Strategies: Understanding the Risks for Failure and Resistance
Saye Khoo
University of Liverpool, Liverpool, UK
5:00 PM5:00 PM
Panel Discussion
Brenda E. Crabtree Ramírez
National Institute of Medical Science and Nutrition Salvador Zubiran, Mexico City, Mexico
5:00 PM5:00 PM
Panel Discussion
Suzanne McCluskey
Massachusetts General Hospital, Boston, MA, USA
5:00 PM5:00 PM
Panel Discussion
Anna Turkova
MRC Clinical Trials Unit at UCL, London, UK
5:30 PM5:30 PM
Discussion with Audience Questions and Answers
MAR12
4:00 PMto5:30 PMPDT
12:00 PMto5:00 PMPDT
Putting People at the Center of Prevention: New Models of Delivery
4:00 PM4:00 PM
49 - Leveraging Private-Sector Pharmacies to Expand Reach of Biomedical HIV Prevention Interventions
Katrina Ortblad
Fred Hutchinson Cancer Center, Seattle, WA, USA
4:20 PM4:20 PM
50 - Empowering Communities: A Peer-Based Model for Expanding Equitable Access to PrEP and PEP in Mexico
Alaín Pinzón
Vihve Libre, Mexico City, Mexico
4:40 PM4:40 PM
51 - We’ll Come to You: A Mobile Clinic Preexposure Prophylaxis Delivery Model
Elzette Rousseau
Desmond Tutu HIV Foundation, Cape Town, South Africa
5:30 PM5:30 PM
Discussion with Audience Questions and Answers